Concepedia

Matthew R. Reese

MR

28

Publications

3.2K

Citations

21

H-Index

2000

Active since

Affiliations

Pfizer (United States)(Current)

Utah State University

University of Alberta

Scripps Research Institute

University of Maryland, Baltimore

Matthew R. Reese is an author at Pfizer (United States) specializing in pharmacology, medicine, and medicinal chemistry.

ORCID

Top concepts

Publications per year

2000–2025

28

Publications

28

An oral SARS-CoV-2 M <sup>pro</sup> inhibitor clinical candidate for the treatment of COVID-19

Dafydd R. Owen, Charlotte Allerton, Annaliesa S. Anderson et al. · Science · 2021 · 1.8K citations · Full text

, , +16

Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19

Britton Boras, Rhys Jones, Brandon J. Anson et al. · Nature Communications · 2021 · 284 citations · Full text

Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19

Britton Boras, Rhys Jones, Brandon J. Anson et al. · 2020 · 158 citations · Full text

Sulfonamide Synthesis via Calcium Triflimide Activation of Sulfonyl Fluorides

Paramita Mukherjee, Cristian P. Woroch, Leah Cleary et al. · Organic Letters · 2018 · 118 citations · Full text

Discovery of Brain-Penetrant, Irreversible Kynurenine Aminotransferase II Inhibitors for Schizophrenia

Amy B. Dounay, Marie Anderson, Bruce M. Bechle et al. · ACS Medicinal Chemistry Letters · 2012 · 88 citations · Full text

, , +13

Rows per page

1–5 of 28